Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Open in API
Filings indexed 746 across all filing types
Latest filing 2020-11-06 Director's Dealing
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2020-11-06 English
10-Q
Interim / Quarterly Report Q3 2020
2020-11-05 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text includes an Item 2.02 about results of operations and financial condition, referencing a press release with financial results for the three and nine months ended September 30, 2020. It also includes Item 5.02 about the appointment of a new director. The document does not contain full financial statements or detailed financial analysis itself but rather announces events and references an attached press release. The presence of management changes (appointment of a director) and financial results announcement in a brief filing suggests this is a regulatory announcement of events rather than a full financial report or detailed management discussion. The document length is under 5,000 characters, and it states the press release is attached but not filed, indicating it is an announcement rather than the report itself. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-11-05 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-29 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-29 English
Regulatory Filings 2020
Regulatory Filings
2020-09-01 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.